Want to join the conversation?
$MNK said its Specialty Brands segment revenue rose 32.1% and was the primary factor of overall net sales growth. Results were helped by solid volume growth in H.P. Acthar Gel (repository corticosteroid injection), unusually strong net sales results for INOMAX gas for inhalation, and incremental volume growth for OFIRMEV.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.